John Aballi - 03 Mar 2026 Form 4 Insider Report for EXAGEN INC. (XGN)

Role
President and CEO, Director
Signature
/s/ Jeffrey G. Black, as attorney-in-fact
Issuer symbol
XGN
Transactions as of
03 Mar 2026
Net transactions value
-$56,827
Form type
4
Filing time
04 Mar 2026, 15:00:02 UTC
Previous filing
25 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
ABALLI JOHN President and CEO, Director C/O EXAGEN INC., 1261 LIBERTY WAY, VISTA /s/ Jeffrey G. Black, as attorney-in-fact 04 Mar 2026 0001843113

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction XGN Common Stock Sale $56,827 -15,698 -2.2% $3.62 687,299 03 Mar 2026 Direct F1
transaction XGN Common Stock Award +2,535 +0.37% $3.08* 689,834 03 Mar 2026 Direct F2, F3
holding XGN Common Stock 40,401 03 Mar 2026 by Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported on this Form 4 represents shares sold by the Reporting Person, at the direction of the Issuer, to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated solely by the Issuer and does not represent a discretionary transaction by the Reporting Person.
F2 The reporting person is voluntarily reporting the acquisition of the Issuer's common stock pursuant to the Employee Stock Purchase Plan ("ESPP").
F3 Represents shares of common stock purchased through ESPP in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).